Clinical Trials on Healthy, Hepatic Insufficiency in Australia

Total 736 results

Elixiron Immunotherapeutics Inc.

Recruiting

First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

Healthy

Australia
Alexion Pharmaceuticals, Inc.

Completed

Bioavailability Study of 2 Oral Formulations of ALXN1840

Healthy

Australia
Karyopharm Therapeutics Inc

Terminated

Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Healthy

Australia
Pulmatrix Inc.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults

Healthy

Australia
Galera Therapeutics, Inc.

Completed

A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers

Healthy

Australia
Emerald Health Pharmaceuticals

Completed

To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers

Healthy

Australia
Arrowhead Pharmaceuticals

Completed

Safety and Tolerability Study of ARC-520 in Healthy Volunteers

Healthy

Australia
CSL Limited

Completed

A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers

Healthy

Australia
Suzhou Ribo Life Science Co. Ltd.

Recruiting

A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects

Healthy Volunteers

Australia
Amckaus PTY LTD.

Recruiting

Aom0319 SAD Study in Healthy Subjects

Healthy Volunteers

Australia
Inmagene LLC

Active, not recruiting

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

Healthy Volunteers

Australia
RANI Therapeutics

Completed

Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule

Healthy Volunteers

Australia
Foresee Pharmaceuticals Co., Ltd.

Completed

Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045

Healthy Volunteers

Australia
Chengdu SciMount Pharmatech Co., Ltd.

Completed

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

Healthy Volunteers

Australia
SIMR (Australia) Biotech Pty Ltd.
Syneos Health

Completed

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

Healthy Volunteers

Australia
RANI Therapeutics

Completed

A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform (RaniPill)

Healthy Volunteers

Australia
Amckaus PTY LTD.
Novotech (Australia) Pty Limited

Recruiting

QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects

Healthy Volunteers

Australia
Shanghai Zhimeng Biopharma, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia

Healthy Volunteers

Australia
BeBetter Med Inc

Completed

Study of Orally Administered BEBT-503 in Healthy Subjects

Healthy Subjects

Australia
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of RBD1016

Healthy Volunteers

Australia
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers

Healthy Volunteers

Australia
RBP4 Pty Ltd
Belite Bio, Inc

Completed

Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses

Healthy Volunteer

Australia
Achaogen, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789

Healthy Volunteers

Australia
KDL Inc.

Unknown

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

End Stage Renal Disease | Hyperphosphatemia

Australia
Royal Perth Hospital
ReCor Medical, Inc.

Recruiting

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. (RESURRECT)

Heart Failure | Chronic Kidney Diseases | End Stage Renal Disease

Australia
The University of Queensland

Unknown

Inspiratory Muscle Training in Patients With End Stage Renal Failure

Renal Failure | Chronic Renal Insufficiency

Australia
Tyra Biosciences, Inc

Recruiting

A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants

Healthy

Australia
BeiGene

Completed

BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants

Healthy

Australia
MyoKardia, Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers

Healthy

Australia
Aeovian Pharmaceuticals, Inc.

Recruiting

Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers

Healthy Participants

Australia
InSilico Medicine Hong Kong Limited

Recruiting

Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

Healthy Subjects

Australia
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
Alebund Pty Ltd

Completed

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Healthy Subjects

Australia
Sonnet BioTherapeutics

Completed

Study of SON-1010 (IL12-FHAB) in Healthy Adults

Healthy Adult

Australia
Supernus Pharmaceuticals, Inc.

Completed

Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects

Healthy Volunteer

Australia
Arthrosi Therapeutics

Completed

The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males

Healthy Volunteers

Australia
Alvotech Swiss AG

Completed

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (ALVOPAD)

Healthy Volunteers

Australia
Hutchison Medipharma Limited

Completed

A Study of HMPL-689 in Healthy Volunteers

Healthy Volunteers

Australia
Medicines for Malaria Venture
Syneos Health; Nucleus Network Ltd

Completed

Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

Healthy Volunteers

Australia
Mateon Therapeutics

Completed

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden (OXi4503)

Neoplasm Metastasis

Australia
Turgut Ardika PTY LTD

Recruiting

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Healthy

Australia
Circadian Therapeutics Ltd
Neuroscience Trials Australia

Completed

First in Human Study of CT-1500 in Healthy Participants

Healthy

Australia
Arrowhead Pharmaceuticals

Completed

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

Healthy

Australia
Medtronic Cardiac Rhythm and Heart Failure

Terminated

Reveal LINQ™ Evaluation of Fluid (REEF)

End Stage Renal Disease

Australia
ModernaTX, Inc.

Recruiting

Study to Investigate Safety and Tolerability of mRNA-0184 Administered at 2 Different Infusion Durations in Healthy Participants

Healthy Participants

Australia
Diceros Therapeutics
Diceros Therapeutics Australia Pty Ltd

Not yet recruiting

Phase 1, SAD/MAD of Verasone™ Administered by Sinonasal Irrigation in Healthy Participants

Healthy Volunteers

Australia
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Safety of AB680 in Healthy Volunteers

Healthy Volunteers

Australia
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers

Healthy Volunteers

Australia
TeneoFour Inc.
Novotech (Australia) Pty Limited

Completed

A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers

Healthy Volunteer

Australia
GenFleet Therapeutics (Australia) Pty Ltd.

Completed

A Study of GFH312 in Healthy Subjects

Healthy | Toxicity

Australia

3

Subscribe